Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Alterity and UniQuest partner to reverse bacterial resistance to antibiotics 2020-12-22 05:42
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases 2020-11-17 01:09
Alterity announces approval of US patent for next generation compounds to treat neurodegenerative diseases 2020-11-16 21:42
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study 2020-10-27 10:03
New data independently confirms and extends laboratory findings and expands safety profile of ATH434 2020-08-04 09:33
Alterity Releases Appendix 4C - Q4 FY20 Quarterly Cash Flow Report 2020-07-31 06:49
Alterity Therapeutics meeting with US FDA provides development pathway for ATH434 2020-06-30 11:14
Alterity Therapeutics presents data on ATH434 to the American Academy of Neurology 2020-05-21 08:58
Alterity Therapeutics Limited Releases Its Appendix 4C - Q3 FY20 Quarterly Cash Flow Report 2020-04-30 16:35
Alterity Receives Non-Compliance Notice Regarding NASDAQ Minimum Bid Price Requirement 2020-02-07 21:00
1 2 3